IL98090A - Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them - Google Patents
Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing themInfo
- Publication number
- IL98090A IL98090A IL9809091A IL9809091A IL98090A IL 98090 A IL98090 A IL 98090A IL 9809091 A IL9809091 A IL 9809091A IL 9809091 A IL9809091 A IL 9809091A IL 98090 A IL98090 A IL 98090A
- Authority
- IL
- Israel
- Prior art keywords
- propyl
- carbon atoms
- compound
- dihydro
- benzopyran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/521,777 US5073562A (en) | 1990-05-10 | 1990-05-10 | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL98090A0 IL98090A0 (en) | 1992-06-21 |
IL98090A true IL98090A (en) | 1995-07-31 |
Family
ID=24078110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9809091A IL98090A (en) | 1990-05-10 | 1991-05-09 | Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them |
Country Status (16)
Country | Link |
---|---|
US (1) | US5073562A (xx) |
EP (1) | EP0527922B1 (xx) |
JP (1) | JPH05507084A (xx) |
AT (1) | ATE119528T1 (xx) |
AU (1) | AU647487B2 (xx) |
CA (1) | CA2082500A1 (xx) |
DE (1) | DE69108025T2 (xx) |
DK (1) | DK0527922T3 (xx) |
ES (1) | ES2069295T3 (xx) |
GR (1) | GR3015349T3 (xx) |
IE (1) | IE62719B1 (xx) |
IL (1) | IL98090A (xx) |
NZ (1) | NZ238092A (xx) |
PT (1) | PT97614A (xx) |
WO (1) | WO1991017160A1 (xx) |
ZA (1) | ZA913546B (xx) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2677021B1 (fr) * | 1991-05-31 | 1993-10-01 | Upsa Laboratoires | Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
US5352690A (en) * | 1992-07-01 | 1994-10-04 | Eli Lilly And Company | 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
AU2585595A (en) * | 1994-05-25 | 1995-12-18 | G.D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-sulfonimides derivatives, their preparation and their use as leukotriene b4 antagonists |
US5516917A (en) * | 1994-06-08 | 1996-05-14 | G. D. Searle & Co. | Leukotriene B4 antagonists |
CA2201742A1 (en) * | 1994-10-13 | 1996-04-25 | Anthony Daniel Piscopio | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists |
EP0785935A1 (en) * | 1994-10-13 | 1997-07-30 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
EP1127054A4 (en) * | 1998-10-29 | 2006-11-02 | Bristol Myers Squibb Co | INHIBITORS OF IMPDH ENZYME |
AU2001292874B2 (en) | 2000-09-27 | 2006-06-15 | Merck & Co., Inc. | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
EP1347755A2 (en) * | 2000-10-31 | 2003-10-01 | Merck & Co., Inc. | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
US7446127B2 (en) * | 2003-08-27 | 2008-11-04 | Sk Holdings Co, Ltd. | Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
EP1907571B1 (en) | 2005-06-15 | 2017-04-26 | Complete Genomics Inc. | Nucleic acid analysis by random mixtures of non-overlapping fragments |
WO2007044245A2 (en) | 2005-10-07 | 2007-04-19 | Callida Genomics, Inc. | Self-assembled single molecule arrays and uses thereof |
EP2495337A1 (en) | 2006-02-24 | 2012-09-05 | Callida Genomics, Inc. | High throughput genome sequencing on DNA arrays |
CA2850509C (en) | 2011-10-14 | 2023-08-01 | President And Fellows Of Harvard College | Sequencing by structure assembly |
WO2013184754A2 (en) | 2012-06-05 | 2013-12-12 | President And Fellows Of Harvard College | Spatial sequencing of nucleic acids using dna origami probes |
US9476089B2 (en) | 2012-10-18 | 2016-10-25 | President And Fellows Of Harvard College | Methods of making oligonucleotide probes |
US9540685B2 (en) | 2013-03-15 | 2017-01-10 | President And Fellows Of Harvard College | Methods of identifying homologous genes using FISH |
CA2958292A1 (en) | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
BR112022007375A2 (pt) | 2019-10-18 | 2022-07-05 | Univ Leland Stanford Junior | Sequenciamento de tecido intacto em escala clínica e industrial |
US20220228200A1 (en) | 2021-01-19 | 2022-07-21 | 10X Genomics, Inc. | Methods and compositions for internally controlled in situ assays |
EP4347877A1 (en) | 2021-06-01 | 2024-04-10 | 10X Genomics, Inc. | Methods and compositions for analyte detection and probe resolution |
CN117751197A (zh) | 2021-06-02 | 2024-03-22 | 10X基因组学有限公司 | 使用不对称可环化探针的样品分析 |
US20230026886A1 (en) | 2021-07-13 | 2023-01-26 | 10X Genomics, Inc. | Methods for preparing polymerized matrix with controllable thickness |
US20230057571A1 (en) | 2021-08-03 | 2023-02-23 | 10X Genomics, Inc. | Nucleic acid concatemers and methods for stabilizing and/or compacting the same |
WO2023023484A1 (en) | 2021-08-16 | 2023-02-23 | 10X Genomics, Inc. | Probes comprising a split barcode region and methods of use |
US20230242974A1 (en) | 2021-12-27 | 2023-08-03 | 10X Genomics, Inc. | Methods and compositions for rolling circle amplification |
US20230279475A1 (en) | 2022-01-21 | 2023-09-07 | 10X Genomics, Inc. | Multiple readout signals for analyzing a sample |
WO2023164570A1 (en) | 2022-02-23 | 2023-08-31 | Insitro, Inc. | Pooled optical screening and transcriptional measurements of cells comprising barcoded genetic perturbations |
WO2023215603A1 (en) | 2022-05-06 | 2023-11-09 | 10X Genomics, Inc. | Methods and compositions for in situ analysis of v(d)j sequences |
WO2023245190A1 (en) | 2022-06-17 | 2023-12-21 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
WO2024081869A1 (en) | 2022-10-14 | 2024-04-18 | 10X Genomics, Inc. | Methods for analysis of biological samples |
WO2024102736A1 (en) | 2022-11-08 | 2024-05-16 | 10X Genomics, Inc. | Immobilization methods and compositions for in situ detection |
WO2024107887A1 (en) | 2022-11-16 | 2024-05-23 | 10X Genomics, Inc. | Methods and compositions for assessing performance of in situ assays |
WO2024130203A1 (en) | 2022-12-16 | 2024-06-20 | 10X Genomics, Inc. | Methods and compositions for assessing performance |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1384530A (en) * | 1971-07-29 | 1975-02-19 | Fisons Ltd | Chromone derivatives |
EP0017332B1 (en) * | 1979-03-20 | 1985-07-31 | FISONS plc | Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them |
EP0079637B1 (en) * | 1981-11-12 | 1987-01-28 | FISONS plc | Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them |
US4788214A (en) * | 1983-06-24 | 1988-11-29 | Hoffman-La Roche Inc. | 3,4-dihydro-2H-1-benzopyran derivatives |
ZA844519B (en) * | 1983-06-24 | 1985-02-27 | Hoffmann La Roche | Dihydrobenzopyran derivatives |
ZA84345B (en) * | 1983-08-08 | 1985-02-27 | Searle & Co | Substituted dihydrobenzopyrans |
US4665203A (en) * | 1983-08-08 | 1987-05-12 | G. D. Searle & Co. | Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors |
US4778903A (en) * | 1983-12-12 | 1988-10-18 | G. D. Searle & Co. | Substituted dihydrobenzopyrans |
US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
US4546194A (en) * | 1984-05-29 | 1985-10-08 | G. D. Searle & Co. | Substituted chromanon-2-yl alkanols and derivatives thereof |
US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
MX13485A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos |
-
1990
- 1990-05-10 US US07/521,777 patent/US5073562A/en not_active Expired - Fee Related
-
1991
- 1991-05-01 EP EP91910026A patent/EP0527922B1/en not_active Expired - Lifetime
- 1991-05-01 WO PCT/US1991/002981 patent/WO1991017160A1/en active IP Right Grant
- 1991-05-01 DE DE69108025T patent/DE69108025T2/de not_active Expired - Fee Related
- 1991-05-01 AU AU79020/91A patent/AU647487B2/en not_active Ceased
- 1991-05-01 ES ES91910026T patent/ES2069295T3/es not_active Expired - Lifetime
- 1991-05-01 DK DK91910026.3T patent/DK0527922T3/da active
- 1991-05-01 CA CA002082500A patent/CA2082500A1/en not_active Abandoned
- 1991-05-01 AT AT91910026T patent/ATE119528T1/de not_active IP Right Cessation
- 1991-05-01 JP JP91509388A patent/JPH05507084A/ja active Pending
- 1991-05-09 NZ NZ238092A patent/NZ238092A/xx unknown
- 1991-05-09 PT PT97614A patent/PT97614A/pt not_active Application Discontinuation
- 1991-05-09 IE IE158391A patent/IE62719B1/en not_active IP Right Cessation
- 1991-05-09 IL IL9809091A patent/IL98090A/en not_active IP Right Cessation
- 1991-05-10 ZA ZA913546A patent/ZA913546B/xx unknown
-
1995
- 1995-03-09 GR GR950400438T patent/GR3015349T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5073562A (en) | 1991-12-17 |
JPH05507084A (ja) | 1993-10-14 |
ZA913546B (en) | 1992-07-29 |
EP0527922B1 (en) | 1995-03-08 |
DE69108025T2 (de) | 1995-08-10 |
AU7902091A (en) | 1991-11-27 |
DK0527922T3 (da) | 1995-05-22 |
IE911583A1 (en) | 1991-11-20 |
DE69108025D1 (de) | 1995-04-13 |
AU647487B2 (en) | 1994-03-24 |
ES2069295T3 (es) | 1995-05-01 |
GR3015349T3 (en) | 1995-06-30 |
IE62719B1 (en) | 1995-02-22 |
PT97614A (pt) | 1992-01-31 |
ATE119528T1 (de) | 1995-03-15 |
NZ238092A (en) | 1993-10-26 |
EP0527922A1 (en) | 1993-02-24 |
WO1991017160A1 (en) | 1991-11-14 |
CA2082500A1 (en) | 1991-11-11 |
IL98090A0 (en) | 1992-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU647487B2 (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof | |
EP0593478B1 (en) | Leukotriene b 4 antagonists | |
EP0605729B1 (en) | Oxazolidine derivative and pharmaceutically acceptable salt thereof | |
JP4276074B2 (ja) | ペルオキシソーム増殖剤応答性受容体δの活性化剤 | |
EP0243018B1 (en) | Thiolactam-n-acetic acid derivatives, their production and use | |
KR20000016412A (ko) | 신규한 치환 2,4-티아졸리디네디온 유도체, 이의제조 방법 및이를 함유하는 약제학적 조성물 | |
US5604225A (en) | Substituted thiazoles and oxazoles and 2-hydroxy-morpholines | |
US4746669A (en) | Substituted thiazoles as immunoregulants | |
EP0528935B1 (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof | |
US5516917A (en) | Leukotriene B4 antagonists | |
US5192782A (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof | |
US5212198A (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof | |
US5578619A (en) | Alkoxy-substituted dihydrobenzopyran-2-sulfonimides | |
US5380740A (en) | Anti-inflammatory compounds, compositions and method of use thereof | |
JPH04270273A (ja) | チアゾリジン−2,4−ジオン誘導体とその塩及びその製造法 | |
US4855426A (en) | Process of preparing 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins | |
US4761413A (en) | 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins and use in treatment of ulcers | |
IE914409A1 (en) | Anti-inflammatory compounds | |
US4910198A (en) | 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |